APA (7th ed.) Citation

GS, J., SD, L., MS, G., DJ, R., BC, W., K, O., . . . E, B. (2025). Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer. Redox biology, 88, 103895. https://doi.org/10.1016/j.redox.2025.103895

Chicago Style (17th ed.) Citation

GS, Jameson, et al. "Phase IB Trial of High Dose Ascorbic Acid + Nab-paclitaxel + Cisplatin + Gemcitabine in Patients with Untreated Metastatic Pancreatic Cancer." Redox Biology 88 (2025): 103895. https://doi.org/10.1016/j.redox.2025.103895.

MLA (9th ed.) Citation

GS, Jameson, et al. "Phase IB Trial of High Dose Ascorbic Acid + Nab-paclitaxel + Cisplatin + Gemcitabine in Patients with Untreated Metastatic Pancreatic Cancer." Redox Biology, vol. 88, 2025, p. 103895, https://doi.org/10.1016/j.redox.2025.103895.